APA

Gelderblom H. C., Reesink H. W., Beld M. G. H. M., Weegink C. J., Jansen P. L. M., Dijkgraaf M. G. W. & Zaaijer H. L. (20070806). Low-level HCV viraemia after initial response during antiviral therapy: transcription-mediated amplification predicts treatment failure. : Antiviral therapy.

Chicago

Gelderblom Huub C, Reesink Henk W, Beld Marcel G H M, Weegink Christine J, Jansen Peter L M, Dijkgraaf Marcel G W and Zaaijer Hans L. 20070806. Low-level HCV viraemia after initial response during antiviral therapy: transcription-mediated amplification predicts treatment failure. : Antiviral therapy.

Harvard

Gelderblom H. C., Reesink H. W., Beld M. G. H. M., Weegink C. J., Jansen P. L. M., Dijkgraaf M. G. W. and Zaaijer H. L. (20070806). Low-level HCV viraemia after initial response during antiviral therapy: transcription-mediated amplification predicts treatment failure. : Antiviral therapy.

MLA

Gelderblom Huub C, Reesink Henk W, Beld Marcel G H M, Weegink Christine J, Jansen Peter L M, Dijkgraaf Marcel G W and Zaaijer Hans L. Low-level HCV viraemia after initial response during antiviral therapy: transcription-mediated amplification predicts treatment failure. : Antiviral therapy. 20070806.